
Premier's Antimicrobial Stewardship Forum will be held on November 10, 2026 from 12 - 1 pm EST. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Surviving Sepsis Guidelines 2026: Evidence, Controversies, and Practical Implications for Pharmacy
Speaker: Tyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS, Professor and Interim Chair, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Critical Care Pharmacy Specialist, University of Colorado Hospital, Aurora, CO
ACPE Universal Activity Number: 0122-0000-26-042-L01-P [0.1 CEU] [1 Contact Hr.]
Important: When registering for a CE activity, please select the program that aligns with your profession (Pharmacist or Pharmacy Technician). Choosing the correct program is essential to ensure your CE credit is processed accurately and prevents delays in reporting to CPE Monitor.
Date: Nov 10, 2026 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Nov 10, 2026 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Tue, Nov 10, 2026
Objectives
- Describe major updates in the newest Surviving Sepsis recommendations relevant to pharmacist-led critical care management
- Explain current evidence supporting and opposing key guideline recommendations related to fluid resuscitation, vasopressors, corticosteroids, and antimicrobial therapy
- Discuss controversial areas within the updated sepsis guidelines, including resuscitation endpoints, timing of interventions, and individualized hemodynamic management
- Recognize the impact of evolving sepsis evidence on antimicrobial stewardship, diagnostic uncertainty, and medication-related adverse effects
- Translate guideline recommendations to complex critically ill patient cases while recognizing situations where deviation from protocolized care may be clinically appropriate
- Identify opportunities for pharmacists to improve multidisciplinary sepsis care through medication optimization, implementation strategies, and quality improvement initiatives
Speaker(s)/Author(s)
|
Tyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS
|
